Source: Anti-Cancer Drugs. Unidades: FMRP, FFCLRP
Subjects: ANTINEOPLÁSICOS (DESENVOLVIMENTO), CITOTOXINAS, OSTEOSSARCOMA
ABNT
BOGADO, Rodrigo F. E. et al. Bl 6727 and GSK461364 suppress growth and radiosensitize osteosarcoma cells, but show limited cytotoxic effects when combined with conventional treatments. Anti-Cancer Drugs, v. 26, n. 1, p. 56-63, 2015Tradução . . Disponível em: https://doi.org/10.1097/CAD.0000000000000157. Acesso em: 08 set. 2024.APA
Bogado, R. F. E., Pezuk, J. A., Oliveira, H. F. de, Tone, L. G., & Brassesco, M. S. (2015). Bl 6727 and GSK461364 suppress growth and radiosensitize osteosarcoma cells, but show limited cytotoxic effects when combined with conventional treatments. Anti-Cancer Drugs, 26( 1), 56-63. doi:10.1097/CAD.0000000000000157NLM
Bogado RFE, Pezuk JA, Oliveira HF de, Tone LG, Brassesco MS. Bl 6727 and GSK461364 suppress growth and radiosensitize osteosarcoma cells, but show limited cytotoxic effects when combined with conventional treatments [Internet]. Anti-Cancer Drugs. 2015 ; 26( 1): 56-63.[citado 2024 set. 08 ] Available from: https://doi.org/10.1097/CAD.0000000000000157Vancouver
Bogado RFE, Pezuk JA, Oliveira HF de, Tone LG, Brassesco MS. Bl 6727 and GSK461364 suppress growth and radiosensitize osteosarcoma cells, but show limited cytotoxic effects when combined with conventional treatments [Internet]. Anti-Cancer Drugs. 2015 ; 26( 1): 56-63.[citado 2024 set. 08 ] Available from: https://doi.org/10.1097/CAD.0000000000000157